GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings49 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

THE CIGNA GROUP

2.1M$579.6M13.1%$215.27+23.03%
19 qtrssince 2018-Q4
Increased
69
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

1.2M$531.9M12.0%
Increased

TENET HEALTHCARE CORP

6.5M$526.4M11.9%$27.66+195.18%
19 qtrssince 2018-Q4
Decreased
0

DXC TECHNOLOGY CO

9.7M$260.1M5.9%$37.81-30.63%
19 qtrssince 2018-Q4
Increased
66

UNIVERSAL HEALTH SERVICES-B

1.4M$222.5M5.0%$145.08+6.68%
3 qtrssince 2022-Q4
Increased
88

GLOBAL PAYMENTS INC

2.2M$221.1M5.0%$150.66-37.21%
11 qtrssince 2020-Q4
Unchanged
0

CLARIVATE PLC

17.3M$165M3.7%$9.68-2.71%
5 qtrssince 2022-Q2
Increased
78

MCKESSON CORP

378,193$161.6M3.6%$144.46+187.95%
19 qtrssince 2018-Q4
Decreased
0

ALIGHT INC

15.1M$139.5M3.1%$8.15+6.76%
4 qtrssince 2022-Q3
Increased
60

CORTEVA INC

2.1M$119.9M2.7%$49.69+12.87%
15 qtrssince 2019-Q4
Increased
65
IWMIWM
PUT

ISHARES RUSSELL 2000 ETF ETF

600,000$112.4M2.5%
New

US FOODS HOLDING CORP

2.6M$112.3M2.5%$36.59+19.13%
7 qtrssince 2021-Q4
Decreased
0

FISERV INC

881,068$111.1M2.5%$103.02+20.41%
16 qtrssince 2019-Q3
Decreased
0

VALVOLINE INC

2.8M$105.1M2.4%$29.39+24.16%
6 qtrssince 2022-Q1
Decreased
0

FMC CORP

852,243$88.9M2.0%$83.70+11.98%
19 qtrssince 2018-Q4
Increased
55

MYRIAD GENETICS INC

3.7M$86.8M2.0%$18.89+21.68%
16 qtrssince 2019-Q3
Decreased
0

APTIV PLC

827,937$84.5M1.9%$109.15-7.56%
11 qtrssince 2020-Q4
Decreased
0

HCA HOLDINGS INC

263,624$80M1.8%$154.36+90.82%
19 qtrssince 2018-Q4
Decreased
0

BROOKDALE SR LIVING INC

18.6M$78.7M1.8%$4.69-10.51%
19 qtrssince 2018-Q4
Unchanged
0

DUPONT DE NEMOURS INC

1M$74.5M1.7%$80.47+5.13%
11 qtrssince 2020-Q4
Decreased
0
$4.4B
AUM
49
Positions
Q2 2023
Filing
Rating · 4.0
Quarterly Portfolio Change
+5%Q1'22$4.9B-19%Q2'22$4B+0%Q3'22$4B+13%Q4'22$4.5B+1%Q1'23$4.6B-3%Q2'23$4.4B
Activity profile
$ moved · Q2'23
New15%Increased25%Decreased39%Exited21%
Composition
Equity vs derivatives
Equity84%Puts15%Calls2%
Holding period
Avg 2.4 years
<1Q10%1-4Q12%1-2Y18%2Y+59%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.4B across 49 positions as of Q2 2023. Top holdings: CI (13.1%), SPY (12.0%), THC (11.9%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q2 2023 Summary

Active quarter - 5 new positions, 12 exits, 10 increased. Top move: UHS (INCREASED, conviction 88). Portfolio: $4.4B across 49 positions.

Top holdings by portfolio weight

Total AUM$4B
CI13.07%
THC11.87%
DXC5.86%
UHS5.02%
GPN4.98%
CLVT3.72%
MCK3.64%
ALIT3.14%
CTVA2.70%
USFD2.53%
Other2.51%

Portfolio allocation by GICS sector

Sectors8
Healthcare48.63%
Technology18.46%
Basic Materials8.98%
Industrials7.90%
Consumer Cyclical6.61%
Unknown4.66%
Consumer Defensive3.36%
Communication Services1.40%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used